Home/Filings/4/0001193125-25-270166
4//SEC Filing

Baranick Brian 4

Accession 0001193125-25-270166

CIK 0001124140other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 5:29 PM ET

Size

5.7 KB

Accession

0001193125-25-270166

Insider Transaction Report

Form 4
Period: 2025-11-04
Baranick Brian
EVP, GM, Precision Oncology
Transactions
  • Sale

    Common Stock

    2025-11-04$70.08/sh2,858$200,28922,368 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    670
Footnotes (2)
  • [F1]The transaction reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into on May 13, 2024.
  • [F2]In addition to the shares of Common Stock reported on this Form 4, which total 23,038 shares, Mr. Baranick also holds, in the aggregate, an additional 73,080 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

Documents

1 file

Issuer

EXACT SCIENCES CORP

CIK 0001124140

Entity typeother

Related Parties

1
  • filerCIK 0001941313

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 5:29 PM ET
Size
5.7 KB